𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of GSK-3β in Alzheimer's disease pathology

✍ Scribed by Emmanuel Planel; Xiaoyan Sun; Akihiko Takashima

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
230 KB
Volume
56
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of mitochondrial dysfunction in Alz
Role of mitochondrial dysfunction in Alzheimer's disease
✍ Rudy Castellani; Keisuke Hirai; Gjumrakch Aliev; Kelly L. Drew; Akihiko Nunomura 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract Abnormalities in mitochondrial function relate to the spectrum of pathological changes seen in Alzheimer's disease. Here we review the causes and consequences of mitochondrial disturbances in Alzheimer's disease as well as how this information might impact on therapeutic approaches to t

Role of amyloid β peptides in the regula
Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology
✍ S. Kar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract The neuropathological features associated with Alzheimer's disease (AD) brain include the presence of extracellular neuritic plaques composed of amyloid β protein (Aβ), intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, and the loss of basal forebrain chol

The role of growth factors and neuropept
The role of growth factors and neuropeptides in alzheimer's disease
✍ G. K. Wilcock 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

A number of important neurotransmitter deficiencies have been described in Alzheimer's disease, the commonest cause of dementia in people at all ages. Particularly marked is the depletion of acetylcholine, and a number of treatments have been developed which are aimed at correcting this biochemical